共查询到20条相似文献,搜索用时 484 毫秒
1.
2.
3.
4.
5.
6.
7.
8.
9.
P Delvoye D Pierard A Noel B Nusgens J M Foidart C M Lapiere 《The Journal of investigative dermatology》1988,90(3):276-282
The mechanism regulating the deposition of basement membrane components (BMCs) in a polymeric structure at the junction with the connective tissues is not yet understood. Cultures and cocultures of epithelial BMC-producing cells (L2 or PER cells) and fibroblasts were prepared in several experimental conditions and the organization of BMCs was studied by immunofluorescence. The pattern of BMCs in pure cultures of L2 or pulmonary epithelial rat (PER) cells consisted of intra- and extracellular granular deposits. At very high density, the cell contours were also underlined by a disrupted network of BMC deposits. A different fibrillar plexus--containing laminin, collagen type IV, and heparan-sulfate proteoglycan resistant to deoxycholate treatment and distant from the cell membrane--was observed in cocultures of L2 or PER cells with fibroblasts. Fibrils of fibronectin and/or collagen type I were most often dissociated from this plexus of BMCs. Similar results were obtained by adding a conditioned medium of L2 or PER cells to confluent fibroblasts, even when the cells were killed. Pure laminin also bound to the fibroblast layer. A coated film of fibronectin or polymeric collagen type I was unable to bind BMC provided by a conditioned medium. It is suggested that molecule(s) synthesized by fibroblasts and deposited in the pericellular matrix are involved in the assembly of BMCs. 相似文献
10.
11.
12.
13.
14.
阿维A治疗重症银屑病临床疗效与安全性评价 总被引:9,自引:1,他引:9
目的 评价阿维A治疗重症银屑病的临床疗效与安全性。方法 24例重症银屑病患者采用阿维A治疗,剂量为 20~50mg/d,平均疗程 4~8周。结果 治疗重症银屑病有效率为 79. 2%,其中斑块状寻常性银屑病、红皮病型银屑病、泛发性脓疱型银屑病、掌跖脓疱病有效率分别为 62. 5%, 75. 0%, 100%, 88. 9%;且阿维A治疗剂量与副作用间有相关性。结论 阿维A治疗重症银屑病临床疗效显著,长时间于临床监测下服用阿维A未出现严重的毒副作用。 相似文献
15.
16.
17.
18.
19.
20.
Perrin C Langbein L Schweizer J Cannata GE Balaguer T Chignon-Sicart B Garzon JM Benchetrit M Michiels JF 《The American Journal of dermatopathology》2011,33(2):131-139
Onychomatricoma (OM) is an uncommon benign tumor of the nail thought to exhibit differentiation limited toward the nail matrix. Four recent articles from our laboratory have shown, in some respect, a morphological and immunohistochemical homology between the nail unit and the hair follicle at the level of the matrix and isthmus. The purposes of this article are as follows: to investigate whether the sequential pattern of hair keratin expression in the normal nail matrix is maintained in OM, to compare and contrast follicular tumors with matrix differentiation in OM, and to furnish morphological and immunohistochemical markers of the onychogenic capacity of OM. Formalin-fixed paraffin sections from 6 OM were examined using specific keratin (K) antibodies for the matrix, nail bed, and nail isthmus. Hair keratins were expressed in a sequential pattern similar to normal nail matrix. In 3 cases where the cavities were completely lined by the fibroepithelial projections, the morphological aspect and the pattern of expression of K5, K17, K6, K16, and K75 suggested a differentiation toward the nail bed and the nail isthmus. This study shows for the first time that OM can recapitulate the entire nail unit with differentiation toward the nail bed and the nail isthmus. We have identified new histopathological and immunohistochemical features in OM, and we have abridged the diversity of its histological presentation in 2 main patterns: a lobulated or foliated pattern, observed principally on transverse section, and a "glove-finger" mono- or multidigitate pattern, observed mainly on longitudinal section. We have also concluded that OM is not a nail variant of trichoblastoma, pilomatricoma, or other pilar tumors. The concept of epithelial onychogenic tumor with onychogenic mesenchyme could shed more light about the true nature of this peculiar mixed tumor. However, the term OM is short and sanctioned by usage, which justifies keeping it. 相似文献